newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA

TORRANCE, Calif., May 31, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX:EMMA), a leader in sickle cell disease treatment, announced today that it has received a Medicine Registration Certificate (DRN-10164/23)